Press release
Colorectal Cancer Market Size And Global Industry Forecast 2034
Colorectal Cancer Market
The Colorectal Cancer (CRC) Market addresses one of the most common and deadly cancers worldwide. CRC is a major global health burden, ranking among the top three most diagnosed cancers and a leading cause of cancer-related deaths. While incidence is higher in developed countries due to aging populations and lifestyle factors, early detection and advanced treatments have significantly improved survival rates in recent decades.
The market is driven by screening programs, precision medicine, immunotherapy adoption, and minimally invasive surgical techniques. Over the next decade, growth will be fueled by liquid biopsy technologies, artificial intelligence (AI) in diagnostics, and innovative targeted therapies that address genetic mutations like KRAS, NRAS, and BRAF.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/70847
Market Overview
• Market Size 2024: USD 18.5 billion
• Forecast 2034: USD 32.4 billion
• CAGR (2024-2034): 5.8%
Key Highlights:
• Rising adoption of colonoscopy, FIT, and Cologuard screening programs.
• Increasing uptake of immunotherapies and targeted agents for metastatic CRC.
• Expanding use of robotic-assisted and laparoscopic surgeries for early-stage disease.
• Development of circulating tumor DNA (ctDNA) tests for minimal residual disease detection.
Market Drivers:
• Growing incidence due to lifestyle factors such as obesity, sedentary behavior, and poor diet.
• Government-backed screening and awareness programs in high-prevalence countries.
• Technological advances in diagnostics and therapeutics.
Market Challenges:
• Low screening uptake in low-income regions.
• Resistance to targeted therapies in advanced CRC.
• High treatment costs limiting access in developing countries.
Leading Players:
• Roche Holding AG
• Merck & Co., Inc.
• Amgen Inc.
• Pfizer Inc.
• Bristol Myers Squibb (BMS)
• Eli Lilly and Company
• Novartis AG
• Guardant Health, Inc.
• Illumina, Inc.
• Exact Sciences Corporation
Segmentation Analysis
By Product
• Chemotherapy Agents
• Targeted Therapy Agents (EGFR Inhibitors, VEGF Inhibitors, BRAF Inhibitors, KRAS Inhibitors)
• Immunotherapy (Checkpoint Inhibitors, Cancer Vaccines)
• Diagnostic Kits & Reagents
• Surgical Devices
By Platform
• Pharmaceuticals
• Diagnostics
• Medical Devices
By Technology
• Colonoscopy & Endoscopic Screening
• FIT & FOBT Tests
• Next-Generation Sequencing (NGS)
• Liquid Biopsy
• Robotic-Assisted Surgery
By End Use
• Hospitals
• Specialty Oncology Clinics
• Diagnostic Laboratories
• Ambulatory Surgical Centers
By Application
• Early-Stage Colorectal Cancer
• Metastatic Colorectal Cancer
Segmentation Summary:
Pharmaceuticals dominate due to the high demand for chemotherapy, targeted therapies, and immunotherapies. However, diagnostics are gaining rapid traction as screening uptake increases globally.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70847
Regional Analysis
North America
• Largest market share, driven by well-established screening programs, high awareness, and rapid adoption of novel therapies.
• The U.S. leads in liquid biopsy development and genomic profiling for CRC.
Europe
• Strong CRC screening initiatives, especially in Western Europe.
• Germany, France, and the UK dominate due to robust healthcare infrastructure and early detection efforts.
Asia-Pacific
• Fastest-growing market due to increasing incidence, lifestyle changes, and government cancer screening programs.
• Japan, China, and South Korea are investing in CRC awareness and AI-based diagnostic tools.
Middle East & Africa
• Limited access to advanced screening and treatment in many regions.
• Gradual improvement in oncology care in urban centers.
Latin America
• Brazil and Mexico lead CRC diagnosis and treatment adoption.
• Expanding private healthcare and diagnostic capabilities boosting market growth.
Regional Trends Summary:
North America remains the innovation leader, while Asia-Pacific offers the highest CAGR due to large population, rising awareness, and expanding healthcare investments.
Market Dynamics
Key Growth Drivers
• Integration of AI in colonoscopy for improved polyp detection rates.
• Expansion of genetic testing to guide personalized therapy.
• Increasing uptake of immunotherapy in MSI-high CRC patients.
Key Challenges
• Therapy resistance in metastatic CRC.
• Low screening compliance in certain demographics.
• High treatment costs for advanced-stage disease.
Latest Trends
• Development of combination regimens pairing targeted agents with immunotherapy.
• Increasing use of ctDNA monitoring for recurrence prediction.
• Adoption of robotic-assisted colectomy for reduced recovery times.
• Research into CRC vaccines for prevention in high-risk populations.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/70847/colorectal-cancer-market
Competitor Analysis
Major Players:
1. Roche Holding AG - Avastin, CEA diagnostics portfolio
2. Merck & Co., Inc. - Keytruda for MSI-high CRC
3. Amgen Inc. - Vectibix (Panitumumab)
4. Pfizer Inc. - Targeted CRC therapeutics
5. Bristol Myers Squibb - Opdivo for CRC
6. Eli Lilly and Company - Cyramza (Ramucirumab)
7. Novartis AG - Precision oncology portfolio
8. Guardant Health, Inc. - Guardant Reveal ctDNA test
9. Illumina, Inc. - NGS platforms for CRC genomics
10. Exact Sciences Corporation - Cologuard stool DNA test
Competitive Summary:
The market is competitive, with Roche, Merck, and Amgen leading in pharmaceuticals, while Exact Sciences and Guardant Health are driving innovation in CRC diagnostics. Partnerships between pharma and diagnostics firms are central to advancing personalized care.
Conclusion
The Colorectal Cancer Market is projected to grow from USD 18.5 billion in 2024 to USD 32.4 billion by 2034, at a CAGR of 5.8%. Expansion will be fueled by screening program adoption, precision oncology, and integration of AI in diagnostics and surgery.
This report is also available in the following languages : Japanese (大腸がん市場), Korean (대장암 시장), Chinese (结直肠癌市场), French (Marché du cancer colorectal), German (Markt für Darmkrebs), and Italian (Mercato del cancro colorettale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/70847
Our More Report:
Veterinary Diagnostic Imaging Systems
https://exactitudeconsultancy.com/reports/65923/veterinary-diagnostic-imaging-systems-market
Customized Breast Coil
https://exactitudeconsultancy.com/reports/65925/customized-breast-coil-market
Magnesium Valproate
https://exactitudeconsultancy.com/reports/65927/magnesium-valproate-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Market Size And Global Industry Forecast 2034 here
News-ID: 4143845 • Views: …
More Releases from Exactitiude Consultancy
Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…
NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…
Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…
Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for CRC
Cold Rolled Coil (CRC) Prices, Chart, Index, News and Forecast
Cold Rolled Coil (CRC) Prices (0.03" x 48-60" Wide, FOB Mill USA): YoY Analysis and 2025 Outlook
The Cold Rolled Coil (CRC) market in the United States has shown notable price fluctuations between 2023 and 2024, reflecting shifting market dynamics, regional demand patterns, and evolving supply conditions. CRC, commonly used in automotive, appliance, and construction industries, is highly sensitive to economic trends and industrial activity levels.
Get the Real-Time Price Analysis: https://www.expertmarketresearch.com/price-forecast/crc-price-forecast/requestsample
In…
Industry Leader CRC Transport Expands Auto Transport Services Nationwide
CRC Transport strengthens its footprint with expanded vehicle shipping and fleet logistics services, ensuring reliable transport for businesses and individuals.
Image: https://www.globalnewslines.com/uploads/2025/03/66f8b949bd58a433ce3f4cd0883e60c1.jpg
CRC Transport LLC [https://crctransport.us/], a leading provider of auto transport services [https://web.facebook.com/crctransportllc?_rdc=1&_rdr], is expanding operations across the United States to meet growing demand. The company is increasing its capacity to ensure businesses and individuals can access reliable and efficient vehicle transportation solutions.
With over a decade of industry experience, CRC Transport…
Omni Tanker and SOMAC CRC Partner to Revolutionise Composites Manufacturing in A …
The Sovereign Manufacturing Automation for Composites CRC (SOMAC CRC) is proud to announce a collaboration with the University of New South Wales (UNSW Sydney) and Omni Tanker to spearhead a digital transformation in composites manufacturing.
Omni Tanker is set to create a "digital twin" of its pilot production plant, a move that marks a significant leap towards optimising composites manufacturing. This digital twin, working alongside physical production facilities, is poised to…
Behavioral Rehabilitation Market – Future Trends Landscape 2025 | CRC Health, …
Behavioral Rehabilitation Market: Snapshot
People might get several behavioral addictions due to various reasons, and these addictions can severely harm their health from a long term perspective. Most of the addictions might not go away by themselves. To resolve such issues, highly reliable methodologies are needed, and behavioral rehabilitation is a set of techniques that could achieve the same if utilized properly.
Behavioral addiction treatments and rehabilitation activities have been going since…
Behavioral Rehabilitation Market - Global Trends 2025 | CRC Health, Magellan Hea …
Behavioral Rehabilitation Market: Snapshot
People might get several behavioral addictions due to various reasons, and these addictions can severely harm their health from a long term perspective. Most of the addictions might not go away by themselves. To resolve such issues, highly reliable methodologies are needed, and behavioral rehabilitation is a set of techniques that could achieve the same if utilized properly.
Request Sample Copy of the Report @
https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2579
Behavioral addiction treatments…
Global Semiconductor Double Detection Experiments Market 2017 - Crc Press, Axcel …
The Semiconductor Double Detection Experiments Market 2017 examines the performance of the Semiconductor Double Detection Experiments market, enclosing an in-depth judgment of the Semiconductor Double Detection Experiments market state and the competitive landscape globally. This report analyzes the potential of Semiconductor Double Detection Experiments market in the present as well as the future prospects from various angles in detail.
The Global Semiconductor Double Detection Experiments Market 2017 report includes Semiconductor Double…
